Wholesale of pharmaceutical and medical goods
NORMEDIN AS
Revenue 2024
NOK 683,000
Operating profit
NOK −105,000
Equity
NOK 443,000
Incorporated
1989
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 683k | |
| Total operating costs | 788k | |
| Operating profit (EBIT) | −105k | |
| Net financial items | −5k | |
| Profit for the year | −86k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 500k | |
| of which current assets | 465k | |
| Equity | 443k | |
| Total liabilities | 57k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.